Orogen Royalties Announces Annual Equity Compensation Grant

Orogen Royalties (OTCQB: OGNNF) announced annual equity awards: 132,000 RSUs, 29,000 DSUs and 618,000 stock options granted to directors, officers, employees and consultants under its Omnibus Equity Incentive Compensation Plan.

Rhea-AI Summary

Orogen Royalties (OTCQB: OGNNF) announced annual equity awards: 132,000 RSUs, 29,000 DSUs and 618,000 stock options granted to directors, officers, employees and consultants under its Omnibus Equity Incentive Compensation Plan.

RSUs vest in two years; DSUs vest 50% on year three and 50% on year four and settle on termination; options expire in five years, exercise price $3.12 and vest over three years with 25% immediate vesting. Grants are subject to TSX Venture Exchange acceptance.

Argus Feb 17 session

-0.11% close to close Open Argus

Details

News Market Reaction – OGNNF

On Feb 17, the first trading day after this news, OGNNF closed 0.11% below the previous close.

Data tracked by StockTitan Argus for the Feb 17 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

VANCOUVER, BC / ACCESS Newswire / February 13, 2026 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") announces that, as part of the Company's annual share-based compensation program, the Board of Directors have authorized a grant of 132,000 Restricted Share Units (RSUs), 29,000 Deferred Share Units (DSUs), and 618,000 incentive Stock Options to directors, officers, employees, and consultants. The grant has been authorized pursuant to the Company's Omnibus Equity Incentive Compensation Plan that was approved by shareholders June 27, 2025.

The RSUs awarded will fully vest on the second anniversary of the date of grant. The DSUs awarded will vest 50% each on the third and fourth anniversaries of the grant date and will settle on the termination of service. The Stock Options have a life of five years, an exercise price of $3.12, and will vest over three years including 25% that will vest immediately followed by 25% on the first, second, and third anniversaries from the date of grant.

These equity-based compensation grants are subject to regulatory acceptance of the TSX Venture Exchange.

About Orogen Royalties Inc.

Orogen Royalties is focused on organic royalty creation and royalty acquisitions on precious and base metal discoveries in western North America. The Company's royalty portfolio includes the Ermitaño gold and silver Mine in Sonora, Mexico (2.0% NSR royalty) operated by First Majestic Silver Corp. The Company is well financed with several projects actively being developed by joint venture partners.

On Behalf of the Board
OROGEN ROYALTIES INC.

Paddy Nicol
President & CEO

To find out more about Orogen, please contact Paddy Nicol, President & CEO at 604-248-8648, and Marco LoCascio, Vice President, Corporate Development at 604-248-8648. Visit our website at www.orogenroyalties.com.

Orogen Royalties Inc.
1015 - 789 West Pender Street
Vancouver, BC
Canada V6C 1H2
info@orogenroyalties.com

SOURCE: Orogen Royalties Inc

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Orogen Royalties (OGNNF) grant on February 14, 2026?

Orogen granted RSUs, DSUs and stock options to its team and consultants. According to Orogen Royalties, the grant totals 132,000 RSUs, 29,000 DSUs and 618,000 stock options under the company's omnibus plan approved June 27, 2025.

What are the vesting terms for the RSUs and DSUs in the OGNNF grant?

The RSUs and DSUs follow multi-year vesting schedules. According to Orogen Royalties, RSUs vest in full on the second anniversary; DSUs vest 50% on the third and 50% on the fourth anniversary and settle on termination of service.

What are the exercise price, life and vesting schedule for the OGNNF stock options?

Options carry a five-year term with staged vesting and a stated exercise price. According to Orogen Royalties, options expire in five years, have a $3.12 exercise price, and vest over three years with 25% immediate vesting then 25% each anniversary.

Are the Orogen Royalties (OGNNF) equity grants subject to regulatory approval?

Yes, the grants await exchange acceptance before becoming effective. According to Orogen Royalties, the equity-based compensation grants are subject to the acceptance of the TSX Venture Exchange prior to implementation.

Under which plan were the OGNNF 2026 equity awards authorized?

The grants were made under the company's omnibus equity incentive plan approved by shareholders. According to Orogen Royalties, the awards were authorized pursuant to the Omnibus Equity Incentive Compensation Plan approved June 27, 2025.

How will DSUs granted by Orogen Royalties (OGNNF) be settled for recipients who leave service?

DSUs are designed to settle on termination of service with staged vesting. According to Orogen Royalties, DSUs vest 50% on year three and 50% on year four and will be settled when the recipient's service terminates.